Viral mitochondriopathy in COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), disrupts cellular mitochondria, leading to widespread chronic inflammation and multi-organ dysfunction. Viral proteins cause mitochondrial bioenergetic collapse, disrupt mitochondrial dyna...
Saved in:
| Main Authors: | Tsung-Hsien Chen, Tien-Hsin Jeng, Ming-Yang Lee, Hsiang-Chen Wang, Kun-Feng Tsai, Chu-Kuang Chou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Redox Biology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231725002794 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nitazoxanide controls virus viability through its impact on membrane bioenergetics
by: Noureddine Hammad, et al.
Published: (2024-12-01) -
SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy
by: Matteo Bolis, et al.
Published: (2025-03-01) -
Rechargeable Potent Anti‐Viral Cotton Grafted with a New Quaternized N‐Chloramine
by: Sarah Currie, et al.
Published: (2022-12-01) -
Clinical effectiveness of oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during Omicron JN.1 subvariant wave: a US-based propensity-matched cohort study
by: Wan-Hsuan Hsu, et al.
Published: (2025-05-01) -
Comprehensive insights into the therapeutic effects of baicalein and baicalin against SARS-COV-2 infection
by: Cheng-Han Lin, et al.
Published: (2025-08-01)